Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Martinez Antonio Mancebo; Serrano Paula Nunez; Fernandez de Canete Camacho Jose Carlos; Moreno Planas Jose Maria

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2021 | Volume:21 | Issue:9 Page(s): 0-0

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals

Author(s)

Martinez Antonio Mancebo | Serrano Paula Nunez | Fernandez de Canete Camacho Jose Carlos | Moreno Planas Jose Maria | Issue Writer Certificate

Keywords

HCV RNA Levels

Hepatitis C Virus Core Antigen

Direct Acting Oral Antivirals

Abstract

Background: Affordable and effective diagnostic and treatment monitoring algorithms are urgently needed to achieve the global elimination of hepatitis C virus (HCV) infection. Methods: A total of 274 patients were treated with direct-acting antivirals (DAAs) in the Spanish Hospital of Albacete between 2004 and 2020. This study compared the enzyme-immunoassay technique for HCV core antigen (HCVcAg) with the determination of RNA of HCV (HCV RNA) by polymerase chain reaction (PCR) in monitoring treatment with DAA, setting the lower limit of detection of HCVcAg < 3 fmol/L and RNA < 10 IU/mL. In all cases, the P value of differences associated with the contrast test was less than or equal to 0. 05. Results: We evaluated the viral loads of our patients before treatment, during their treatment, and after its completion. The HCV RNA quantification at diagnosis was 2309327 IU/mL. The mean HCVcAg load was 5972 fmol/L. There was a strong correlation between HCVcAg levels andRNAlevels with a Spearman rho of 0. 832 (P< 0. 01). TheHCVcAg sensitivity at diagnosis was 99%, but the specificity could not be calculated because there were no true negatives or false positives at this point. Twelve weeks after treatment, in patients with treatment failure, we obtained a mean of 19084 IU/mL for RNA, while for HCVcAg, the mean was 103 fmol/L. At this time point, we also found a strong correlation between HCVcAg levels and HCV RNA Levels with a Spearman rho of 0. 775 (P < 0. 01). Finally, the virological cure was achieved in 99% of our patients. The results for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 100%, 99. 87%, 86. 33%, and 100%, respectively. Conclusions: HCVcAg determination is an excellent alternative to HCV RNA in the assessment of treatment response. This is particularly relevant in lower-and middle-income countries and resource-limited settings where the high cost of labor, equipment, and reagents can prohibit molecular testing.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

Martinez, Antonio Mancebo, Serrano, Paula Nunez, Fernandez de Canete Camacho, Jose Carlos, & Moreno Planas, Jose Maria. (2021). Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals. HEPATITIS MONTHLY, 21(9), 0-0. SID. https://sid.ir/paper/987434/en

Vancouver: Copy

Martinez Antonio Mancebo, Serrano Paula Nunez, Fernandez de Canete Camacho Jose Carlos, Moreno Planas Jose Maria. Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals. HEPATITIS MONTHLY[Internet]. 2021;21(9):0-0. Available from: https://sid.ir/paper/987434/en

IEEE: Copy

Antonio Mancebo Martinez, Paula Nunez Serrano, Jose Carlos Fernandez de Canete Camacho, and Jose Maria Moreno Planas, “Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals,” HEPATITIS MONTHLY, vol. 21, no. 9, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/987434/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops